Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia.
Open Access
- 1 February 1992
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 12 (2) , 800-810
- https://doi.org/10.1128/mcb.12.2.800
Abstract
A nonrandom chromosomal translocation breakpoint, t(15;17)(q22;q21), is found in almost all patients with acute promyelocytic leukemia (APL). Most of these breakpoints occur within the second intron of the retinoic acid receptor-alpha (RARA) gene. We screened a cDNA library of APL and have identified and sequenced a cDNA transcribed from the t(15;17) translocation breakpoint. The 5' end of cDNA p1715 consists of 503 bp of the RARA exon II sequence. A 1.76-kb cDNA without homology to any known gene available in GenBank was found truncated downstream. This cDNA sequence was assigned to chromosome 15 by dot blot hybridization of the flow cytometry-sorted chromosomes. We designate this fusion cDNA RARA/myl, which is different from myl/RARA reported by de The et al. (H. de The, C. Chomienne, M. Lanotte, L. Degos, and A. Dejean, Nature (London) 347:558-561, 1990). This result demonstrates that the two different types of hybrid mRNA can be transcribed from this breakpoint. We screened a non-APL cDNA library and identified a 2.8-kb myl cDNA. This cDNA is able to encode a polypeptide with a molecular weight of 78,450. Alternative splicing of the myl gene which resulted in myl proteins with different C terminals was found. Southern blot analysis of the genomic DNA isolated from 17 APL patients by using the myl DNA probe demonstrated that the myl gene in 12 samples was rearranged. Northern (RNA) blot analysis of RARA gene expression in two APL RNA samples showed abnormal mRNA species of 4.2 and 3.2 kb in one patient and of 4.8 and 3.8 kb in another patient; these were in addition to the normal mRNA species of 3.7 and 2.7-kb. The myl DNA probe detected a 2.6-kb abnormal mRNA in addition to the normal mRNA species of 3.2, 4.2, and 5.5 kb. Using the polymerase chain reaction, we demonstrated that both RARA/myl and myl/RARA were coexpressed in samples from three different APL patients. From this study, we conclude that the t(15;17) translocation breakpoint results in the transcription of two different fusion transcripts which are expected to be translated into fusion proteins.Keywords
This publication has 42 references indexed in Scilit:
- Mapping of the human retinoic acid receptor to the q21 band of chromosome 17Human Genetics, 1988
- Identification of a receptor for the morphogen retinoic acidNature, 1987
- A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemiaNature, 1987
- Construction of Human Chromosome-specific DNA Libraries from Flow-sorted ChromosomesCold Spring Harbor Symposia on Quantitative Biology, 1986
- An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.Proceedings of the National Academy of Sciences, 1984
- Biological implications of consistent chromosome rearrangements in leukemia and lymphoma.1984
- Activation of the c-myc gene by translocation: a model for translational control.Proceedings of the National Academy of Sciences, 1983
- Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications.1983
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1983
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976